Skip to main content
Caplight Logo









Cytolytics GmbH

Cytolytics GmbH

Private
TübingenHealthcare & Life Scienceshttps://cytolytics.de/

Last Round

Grant

Oct 30, 2024

Total Funding Raised

$549,000

Company Overview

Cytolytics GmbH is a medical technology company that provides an AI-based cloud software platform for the automated analysis of flow cytometry data for researchers and healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

flow cytometryflow cytometry analysisbioinformaticscytometry softwareautomated data analysisbioinformatics toolsmachine learningdata visualizationvertical SaaSclinical diagnosticsdimensionality reductionbiotech softwarelab automationbioinformatics consultingsingle cell analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytolytics GmbH Comparables

Compare Cytolytics GmbH with similar companies based on industry and business-model similarity.

Cytolytics GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Miltenyi Biotec
69%
Danaher
66%
Sartorius Aktiengesellschaft
62%

Cytolytics GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 30, 2024
GrantSep 30, 2024
Pre SeedAug 16, 2022

Key People

Founding team and executive leadership

Serina Pinar

Founder l Chief Operating Officer, Founder l Chief Strategy Officer

Founding Team

Can Pinar

Founder and CEO

Founding Team

Cytolytics GmbH Investors

Notable investors and investment history

Cytolytics GmbH investors
InvestorRounds
Invest BW InnovationsförderungGrant
State of Baden-WürttembergGrant
L-BankPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 30, 2024

    $336K raised in grant funding.

  • Oct 26, 2024

    Monthly visitors grew 308% MoM, reaching 494.

Cytolytics GmbH Filings

Explore SEC and related filing metadata, where available.

Cytolytics GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cytolytics GmbH's valuation, stock price, and market status.

Is Cytolytics GmbH a public or private company?

Cytolytics GmbH is a private company.

What is the current stock price of Cytolytics GmbH?

Cytolytics GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Cytolytics GmbH worth (valuation)?

Valuation information for Cytolytics GmbH is not publicly available.

Can I buy Cytolytics GmbH stock?

Cytolytics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cytolytics GmbH's last funding round?

Cytolytics GmbH's most recent funding round was Grant on October 30, 2024.

Who are the main investors in Cytolytics GmbH?

Key investors in Cytolytics GmbH include Invest BW Innovationsförderung, State of Baden-Württemberg, L-Bank.

Will Cytolytics GmbH IPO soon?

No public IPO plans have been announced for Cytolytics GmbH.

How can I track Cytolytics GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cytolytics GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTübingen
Employee Range7
Year Founded2020
Last FundingOct 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?